Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2
{{output}}
The Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR) families are among the key oncogenic receptors targeted for developing safe and effective drug therapies for cancer. Upon activation, these receptors primarily ... ...
